Medicare Enrolled
Dr. William Silverman, D.O.
Family Medicine · Maitland, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Silverman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Silverman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Silverman
Dr. William Silverman is a family medicine in Maitland, FL, with 20 years in practice. Based on federal Medicare data, Dr. Silverman performed 4,990 Medicare services across 2,521 unique beneficiaries.
Between the years covered by Open Payments, Dr. Silverman received a total of $20,376 from 78 pharmaceutical and/or device companies across 1171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Silverman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 6% volume in FL$ $20,376 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,990
Medicare services
Top 6% in FL for family medicine
2,521
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~250 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 836 | $86 | $200 |
| Lipid panel (cholesterol and triglycerides) | 316 | $13 | $61 |
| Complete blood count (CBC) with differential | 306 | $8 | $26 |
| Blood draw (venipuncture) | 280 | $8 | $10 |
| Comprehensive metabolic blood panel | 250 | $10 | $40 |
| Urine microalbumin (protein) analysis | 231 | $6 | $40 |
| Creatinine test (kidney function) | 213 | $5 | $20 |
| Remote patient monitoring management, 20 min/month | 210 | $36 | $80 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 196 | $30 | $50 |
| Remote patient monitoring device, 30 days | 192 | $37 | $60 |
| Hemoglobin A1c test (diabetes monitoring) | 189 | $10 | $43 |
| Thyroid stimulating hormone (TSH) test | 170 | $16 | $80 |
| Free thyroxine (T4) test | 166 | $9 | $25 |
| Thyroid hormone, t3 measurement, total | 132 | $14 | $30 |
| PSA test (prostate cancer screening) | 110 | $18 | $78 |
| Testosterone (hormone) level, total | 102 | $25 | $128 |
| Vitamin D level test | 99 | $29 | $75 |
| Magnesium level test | 77 | $7 | $31 |
| Automated urinalysis | 76 | $2 | $16 |
| Creatine kinase (cardiac enzyme) level, total | 76 | $6 | $28 |
| Uric acid level test | 76 | $4 | $19 |
| Flu vaccine administration | 76 | $30 | $35 |
| Annual wellness visit, follow-up | 75 | $126 | $250 |
| Flu vaccine, high-dose | 73 | $72 | $90 |
| Annual depression screening | 63 | $18 | $25 |
| Detection test by immunoassay with direct visual observation for influenza virus | 62 | $16 | $40 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 50 | $34 | $100 |
| Testing for presence of drug, read by direct observation | 34 | $12 | $50 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 32 | $283 | $300 |
| Pneumonia vaccine administration | 32 | $24 | $25 |
| Office visit, established patient, complex (40-54 min) | 28 | $128 | $250 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 27 | $12 | $40 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 24 | $16 | $40 |
| Transitional care management services for problem of at least moderate complexity | 24 | $158 | $300 |
| COVID-19 vaccine (Moderna bivalent) | 19 | $135 | $200 |
| C-peptide (protein) level | 16 | $20 | $40 |
| COVID-19 vaccine administration | 15 | $24 | $25 |
| Electrocardiogram (EKG), 12-lead | 13 | $11 | $50 |
| Advance care planning consultation, first 30 min | 13 | $65 | $100 |
| New patient office visit (45-59 min) | 11 | $87 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,376
Total received (2018-2024)
Avg $2,911/year across 7 years
Top 1% in FL for family medicine
78
Companies
1,171
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,360 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,762
2023$2,425
2022$2,623
2021$3,247
2020$3,371
2019$3,564
2018$3,384
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,714
Novo Nordisk Inc
$1,548
Lilly USA, LLC
$1,305
GlaxoSmithKline, LLC.
$1,056
SANOFI-AVENTIS U.S. LLC
$1,051
Boehringer Ingelheim Pharmaceuticals, Inc.
$951
Amgen Inc.
$950
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$932
AbbVie Inc.
$723
PFIZER INC.
$703
Amarin Pharma Inc.
$589
Otsuka America Pharmaceutical, Inc.
$502
Astellas Pharma US Inc
$468
Janssen Pharmaceuticals, Inc
$399
Kowa Pharmaceuticals America, Inc.
$334
Endo Pharmaceuticals Inc.
$326
Allergan, Inc.
$307
Avanir Pharmaceuticals, Inc.
$302
Radius Health, Inc.
$297
Takeda Pharmaceuticals U.S.A., Inc.
$284
Allergan Inc.
$278
Abbott Laboratories
$274
Regeneron Healthcare Solutions, Inc.
$261
ABBVIE INC.
$242
Gilead Sciences, Inc.
$242
Merck Sharp & Dohme Corporation
$240
Xeris Pharmaceuticals, Inc.
$209
Sunovion Pharmaceuticals Inc.
$177
Novartis Pharmaceuticals Corporation
$176
Phathom Pharmaceuticals, Inc.
$162
Currax Pharmaceuticals LLC
$156
Teva Pharmaceuticals USA, Inc.
$131
Grifols USA, LLC
$127
Sumitomo Pharma America, Inc.
$126
Dexcom, Inc.
$121
Bayer Healthcare Pharmaceuticals Inc.
$108
Exact Sciences Corporation
$99
Bayer HealthCare Pharmaceuticals Inc.
$95
Ultragenyx Pharmaceutical Inc.
$86
Axsome Therapeutics, Inc.
$79
Lundbeck LLC
$78
Mannkind Corporation
$74
IBSA Pharma Inc.
$72
SANOFI PASTEUR INC.
$72
AbbVie, Inc.
$71
Eisai Inc.
$61
Zyla Life Sciences
$54
Scilex Pharmaceuticals Inc.
$49
Covidien LP
$49
Mylan Specialty L.P.
$46
Nalpropion Pharmaceuticals LLC
$42
IDORSIA PHARMACEUTICALS US INC
$42
JAZZ PHARMACEUTICALS INC.
$39
VIVUS, Inc.
$36
MannKind Corporation
$36
Merck Sharp & Dohme LLC
$33
SCILEX PHARMACEUTICALS INC.
$29
Arbor Pharmaceuticals, Inc.
$28
Harmony Biosciences LLC
$25
Nalpropion Pharmaceuticals, Inc.
$24
Endo USA, Inc.
$23
E.R. Squibb & Sons, L.L.C.
$21
Alnylam Pharmaceuticals Inc.
$21
Esperion Therapeutics, Inc.
$18
Aytu BioScience, Inc
$18
Pernix Therapeutics Holdings, Inc.
$17
AMAG Pharmaceuticals, Inc.
$16
Sanofi Pasteur Inc.
$16
Corcept Therapeutics
$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
EISAI INC.
$15
Medtronic MiniMed, Inc.
$15
Daiichi Sankyo Inc.
$14
Horizon Therapeutics plc
$14
ARBOR PHARMACEUTICALS, INC.
$13
VistaPharm, Inc.
$13
US WorldMeds, LLC
$12
Purdue Pharma L.P.
$12
Top 3 companies account for 27.3% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AFREZZA · AIMOVIG · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · AVEED · Aduhelm · Aimovig · Amitiza · Androgel · Auvelity · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BROVANA · BYSTOLIC · Belviq · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CUVITRU · CYCLOSET · Cologuard Collection Kit · Crysvita · DIABETES - DISEASE · DUEXIS · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Enbrel · Epclusa · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Lite system · GEMTESA · GIVLAARI · GVOKE PFS · Horizant · INJECTAFER · INTRAROSA · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LATUDA · LEQVIO · LICART · LINZESS · LONHALA MAGNAIR · LUCEMYRA · LYRICA · Licart · Livalo · Lucemyra/Lofexidine · MAVYRET · MOUNJARO · MOVANTIK · MYRBETRIQ · Motegrity · Myrbetriq · NEXLETOL · NUCALA · NUEDEXTA · Natesto · Nuedexta · OFEV · ONZETRA XSAIL · Otezla · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PillCam · Prolastin-C Liquid · Prolia · QSYMIA · QULIPTA · QUVIVIQ · RELISTOR · RELISTOR ORAL · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYMPROIC · SYNJARDY · SYNTHROID · Saxenda · Synthroid · TESTOPEL · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TREXIMET · TRINTELLIX · TRULICITY · Thyquidity · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · Uloric · Utibron · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · VYNDAMAX · Vascepa · Veozah · Victoza · WAKIX · Wegovy · XARELTO · XIAFLEX · XIFAXAN · Yupelri · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in FL.
Equivalent to $408 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
1,048
Per 100K population
72.8
County median income
$77,011
Nearest hospital
ADVENTHEALTH ORLANDO
5.3 mi
5.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Silverman is a clinical cardiology specialist, with above-average Medicare volume (top 6% in FL), and high industry engagement (low-engagement, top 1%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Silverman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Silverman performed 836 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Silverman receive payments from pharmaceutical companies?
Yes. Dr. Silverman received a total of $20,376 from 78 companies across 1,171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Silverman's costs compare to other family medicines in Maitland?
Dr. Silverman's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Silverman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Maitland
Browse family medicines in Maitland ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in FL
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in FL
Which FL family medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology